Non-Alcoholic Fatty Liver Disease and GLP-1 Treatment in Houston
NAFLD affects millions of Texans, and GLP-1 medications are showing real promise. Here's what Houston patients need to know about treatment options, costs, and local clinics.
Reviewed for accuracy against current FDA guidance, peer-reviewed clinical trial data (STEP, SURMOUNT trials), and manufacturer prescribing information. See our editorial standards.
GLP-1 medications like semaglutide and tirzepatide are showing some of the most promising results for NAFLD that liver specialists have seen in years — and Houston patients are in a strong position to access them. Roughly one in four American adults has fatty liver disease, and rates across the Gulf Coast run higher than the national average, driven by the region's rates of obesity, type 2 diabetes, and metabolic syndrome. Clinics across Houston, Sugar Land, and The Woodlands are increasingly using these medications not just for weight loss, but as a targeted intervention for liver disease specifically. This article covers what NAFLD actually does to your liver, what the clinical trial data on GLP-1 treatment shows, and how to find qualified care in Greater Houston.
1What Is NAFLD and Why Houston Has a Problem
NAFLD is a buildup of fat in liver cells in people who drink little or no alcohol. It exists on a spectrum. At the mild end, you have simple steatosis, which is fat accumulation without inflammation. At the serious end, you have non-alcoholic steatohepatitis, or NASH, which involves active inflammation and can progress to cirrhosis or liver failure. Houston sits at the intersection of several NAFLD risk factors. Harris County has one of the highest rates of obesity and type 2 diabetes in Texas. Long commutes on I-10, the Beltway 8, or Highway 290 leave little time for cooking or exercise. Food deserts exist in large parts of the Fifth Ward, Acres Homes, and sections of southeast Houston near the Port. Hispanic Houstonians face a particularly elevated risk. Research consistently shows higher NAFLD prevalence in Hispanic adults compared to other ethnic groups, and neighborhoods like Gulfton, East End, and Pasadena have large Hispanic populations who may not have had easy access to specialist liver care. Catching NAFLD early, before it becomes NASH, is the goal.
2How GLP-1 Medications Work on the Liver
GLP-1 receptor agonists were originally developed for type 2 diabetes. Researchers noticed early on that patients losing weight on these drugs were also seeing improvements in liver enzyme levels. That led to dedicated studies on liver outcomes. Here is the basic mechanism. GLP-1 receptors exist in the liver, not just in the pancreas and gut. When a GLP-1 medication activates those receptors, it reduces fat production in liver cells, lowers inflammation, and improves insulin sensitivity. Insulin resistance is a primary driver of fat accumulation in the liver, so improving it has a direct effect on NAFLD. The weight loss itself also matters. Studies consistently show that losing 7 to 10 percent of body weight significantly reduces liver fat. Losing more than 10 percent can actually reverse early NASH. GLP-1 medications help patients hit those thresholds far more reliably than diet and exercise alone. The two drugs getting the most attention for liver disease right now are semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound). Both are available through physician-supervised weight loss clinics in Houston.
3What the Clinical Trials Actually Show
The STEP 1 trial published in the New England Journal of Medicine in 2021 showed that once-weekly semaglutide 2.4 mg produced an average weight loss of 14.9% of body weight over 68 weeks in adults with obesity. Weight loss of that magnitude is well above the 10% threshold associated with NASH resolution. A separate Phase 2 trial published in the New England Journal of Medicine in 2023 looked at semaglutide specifically in NASH patients. Patients on semaglutide 2.4 mg were significantly more likely to see NASH resolution on liver biopsy compared to placebo, with 62% of semaglutide patients achieving resolution versus 34% in the placebo group. For tirzepatide, the SURMOUNT-1 trial showed average weight loss of up to 22.5% in adults with obesity over 72 weeks. That is the largest average weight loss ever recorded in a phase 3 obesity drug trial. A dedicated NASH trial for tirzepatide called SYNERGY-NASH is ongoing, but early data looks promising. These are not small studies run by drug companies in a vacuum. The results have been replicated and peer reviewed. The FDA approved semaglutide for chronic weight management in 2021 and tirzepatide in 2023.
4Getting Diagnosed in Houston: Where to Start
Most people with NAFLD have no symptoms. The liver does not have pain receptors, so early-stage disease is silent. The condition is usually discovered through abnormal liver enzyme tests, specifically elevated ALT and AST levels, caught during routine bloodwork. If your primary care doctor finds elevated liver enzymes, the next step is typically an abdominal ultrasound. This is available at most Houston-area imaging centers, including facilities affiliated with Memorial Hermann, Houston Methodist, and UTHealth Houston. Ultrasound can detect fat in the liver but cannot grade severity. For staging NAFLD more precisely, gastroenterologists and hepatologists use FibroScan, a non-invasive ultrasound-based technology that measures liver stiffness and fat content without a biopsy. Several hepatology practices in the Texas Medical Center and in suburban hubs like Sugar Land, The Woodlands, and Pearland offer FibroScan. If your doctor suspects NASH or advanced fibrosis, a liver biopsy may be recommended. This is still the gold standard for diagnosis. But many physicians now use a combination of blood panels, imaging, and clinical scoring tools to avoid biopsy when possible. Ask your doctor about the FIB-4 score, a simple calculation using your age, platelet count, and liver enzymes.
5Working With a Weight Loss Clinic on Liver Health
Physician-supervised weight loss clinics in Houston are well positioned to manage NAFLD alongside obesity, especially now that GLP-1 medications are a mainstream treatment tool. A good clinic will do baseline metabolic bloodwork that includes liver enzymes, fasting glucose, hemoglobin A1c, and a lipid panel before starting you on any medication. When you meet with a provider, be direct about your liver history. Tell them if you have been told you have fatty liver, if you have had abnormal liver enzymes before, or if you have a family history of liver disease. This changes the clinical picture. For example, patients with significant liver fibrosis may need dose adjustments or additional monitoring. Many Houston-area weight loss clinics are clustered in areas easy to reach from major corridors. You will find options along Highway 6 in the Energy Corridor, near Westheimer in Midtown and Upper Kirby, along FM 1960 in north Houston, and in the Clear Lake area off I-45 South. Suburban options in Katy, Cypress, and League City have grown significantly in the last two years as demand for GLP-1 prescriptions increased. Look for clinics with a medical director who is a board-certified physician, not just a nurse practitioner operating independently. Liver disease adds complexity that benefits from physician oversight.
6Insurance Coverage and Cost Reality in Houston
This is where many Houston patients hit a wall. GLP-1 medications for weight loss are expensive without coverage. Wegovy lists at around $1,350 per month and Zepbound at around $1,060 per month before discounts. Coverage depends heavily on your plan and employer. Texas Medicaid does not currently cover GLP-1 medications for obesity. That affects a large number of lower-income Houstonians, particularly those in communities like Sunnyside, Acres Homes, or along the Ship Channel corridor. Commercial insurance coverage varies. Blue Cross Blue Shield of Texas, United Healthcare, Aetna, and Cigna all have plans that cover these medications, but coverage is often tied to a formal obesity diagnosis and documentation of prior weight loss attempts. If you have a concurrent diagnosis of type 2 diabetes, coverage improves significantly, since Ozempic and Mounjaro are approved for diabetes and tend to have better formulary placement. For patients paying out of pocket, Eli Lilly's Zepbound savings card can reduce the cost to around $550 per month for eligible commercially insured patients. Novo Nordisk has a similar program for Wegovy. Compounded semaglutide from FDA-registered 503B compounding pharmacies is another option some Houston clinics use, though the FDA has issued warnings about quality consistency in the broader compounding market. Ask your clinic which compounding pharmacy they use and whether it is 503A or 503B.
7Lifestyle Factors That Amplify GLP-1 Results for Your Liver
GLP-1 medications do a lot of heavy lifting, but what you do alongside the medication matters. The liver responds strongly to dietary changes, particularly reductions in added sugar and refined carbohydrates. Fructose is especially hard on the liver. High-fructose corn syrup, found in sodas, sweetened teas, and a lot of processed snacks common in Houston convenience stores and fast-food chains, drives de novo lipogenesis, a process where the liver converts excess sugar into fat. Cutting sugary drinks alone can meaningfully reduce liver fat over several months. Alcohol use is a separate issue worth addressing honestly with your doctor. Even moderate drinking on top of NAFLD can accelerate progression to NASH. Many patients are surprised to learn that 14 drinks per week is considered heavy drinking by clinical standards. Aerobic exercise has independent benefits for liver fat beyond weight loss. A 2022 meta-analysis in the Journal of Hepatology found that 150 minutes of moderate aerobic activity per week reduced liver fat content even in people who did not lose significant weight. Houston has accessible options year-round, including bayou trail systems, Memorial Park, and the growing network of Brays Bayou Greenway paths through Meyerland, Braeswood, and Bellaire. If you have a gym membership, resistance training also helps by improving insulin sensitivity, which in turn reduces fat storage in the liver.
8When to Involve a Hepatologist
A weight loss clinic can manage NAFLD effectively in its early stages. But some patients need specialist involvement. Here is how to know when to ask for a referral. You should see a hepatologist if your liver enzymes are more than three times the upper limit of normal. You should also seek one if your FibroScan or FIB-4 score suggests advanced fibrosis, if your platelet count is low, or if your doctor finds signs of portal hypertension on imaging. The Texas Medical Center is one of the best concentrations of hepatology expertise in the country. UT Physicians Gastroenterology, Houston Methodist Hepatology, and Baylor Medicine Gastroenterology all have dedicated liver disease programs with clinical trial access. If you are in the suburbs, Houston Methodist Sugar Land and Memorial Hermann The Woodlands both have outpatient gastroenterology services that can handle most NAFLD workups without requiring a trip downtown. Some patients with NASH and advanced fibrosis will be candidates for newer FDA-approved treatments specifically for liver disease. Resmetirom, sold as Rezdiffra, was FDA-approved in 2024 for NASH with moderate to advanced fibrosis. It works differently from GLP-1 drugs and can be used alongside them. Your hepatologist can tell you whether you qualify. The key point is this: do not wait for symptoms. By the time the liver causes pain or visible jaundice, damage is often advanced. Regular bloodwork is your early warning system.
NAFLD is a serious condition, but it is also one of the most reversible metabolic diseases when caught early and treated aggressively. GLP-1 medications give Houston patients a powerful tool that works on weight and liver health at the same time. If you have been told your liver enzymes are elevated or you have been diagnosed with fatty liver, do not put off getting evaluated. Use our Houston Weight Loss Clinic Directory to find a physician-supervised clinic near you and take the first step.
Sources & References
Clinical data referenced in this article is drawn from the FDA drug database, peer-reviewed publications (STEP trials, SURMOUNT trials), and manufacturer prescribing information for Wegovy, Ozempic, Zepbound, and Mounjaro. Pricing figures reflect publicly available estimates and may vary. Insurance coverage information is general guidance — confirm your specific benefits with your plan.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed physician before starting any weight loss medication or program.